M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Bleeding Complications After Surgical Aortic Valve Replacement Compared With Transcatheter Aortic Valve Replacement: Insights From the PARTNER I Trial (Placement of Aortic Transcatheter Valve)
Philippe Généreux,David Cohen,Mathew R. Williams,Michael J. Mack,Susheel Kodali,Lars G. Svensson,Ajay J. Kirtane,Ke Xu,Thomas McAndrew,Raj Makkar,Craig R. Smith,Martin B. Leon +11 more
TL;DR: Major BC was identified as the strongest independent predictor of 1-year mortality among the full cohort and risk-adjusted analyses demonstrated a significant interaction between BC and treatment strategy with respect to mortality, suggesting that BC after SAVR have a greater impact on prognosis than after TAVR.
Journal ArticleDOI
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.
Martin B. Leon,Michael J. Mack,Rebecca T. Hahn,Vinod H. Thourani,Raj Makkar,Susheel Kodali,Maria Alu,Mahesh V. Madhavan,Katherine H. Chau,Mark J. Russo,Samir R. Kapadia,S. Chris Malaisrie,David J. Cohen,Philipp Blanke,Jonathon Leipsic,Mathew R. Williams,James M. McCabe,David L. Brown,Vasilis Babaliaros,Scott M. Goldman,Howard C. Herrmann,Wilson Y. Szeto,Philippe Généreux,Ashish Pershad,Michael T. Lu,John G. Webb,Craig R. Smith,Philippe Pibarot,Partner Investigators +28 more
TL;DR: The safety and effectiveness of transcatheter aortic valve replacement (TAVR) versus surgery for the primary endpoint of death, stroke, or rehospitalization at 1 year was evaluated in the PARTNER 3 trial as discussed by the authors.
Journal ArticleDOI
Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement
Richard J. Jabbour,Akihito Tanaka,Ariel Finkelstein,Michael J. Mack,Corrado Tamburino,Nicolas M. Van Mieghem,Ole De Backer,Luca Testa,Pamela Gatto,Paola Purita,Zouhair Rahhab,Verena Veulemans,Anja Stundl,Marco Barbanti,Roberto Nerla,Jan Malte Sinning,Danny Dvir,Giuseppe Tarantini,Molly Szerlip,Werner Scholtz,Smita Scholtz,Didier Tchetche,Fausto Castriota,Christian Butter,Lars Søndergaard,Mohamed Abdel-Wahab,Horst Sievert,Ottavio Alfieri,John G. Webb,Josep Rodés-Cabau,Antonio Colombo,Azeem Latib +31 more
TL;DR: Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected, as this rare phenomenon is associated with a high in-hospital mortality rate.
Journal ArticleDOI
Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures
Michael J. Mack,Phillip P Brown,Aaron D. Kugelmass,Salvatore L. Battaglia,Lynn G. Tarkington,April W. Simon,Steven D. Culler,Edmund R. Becker +7 more
TL;DR: Interventions for coronary artery disease continue to rise primarily due to an increase in PCI and the proportion of multivessel disease treated is greater, and the difference in adverse outcomes between CABG and PCI remains small and continues to decline.
Journal ArticleDOI
Association of paravalvular regurgitation with 1-year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 valve
Philippe Pibarot,Rebecca T. Hahn,Neil J. Weissman,Marie Arsenault,Jonathan Beaudoin,Mathieu Bernier,Abdellaziz Dahou,Omar K. Khalique,Federico M. Asch,Oumhani Toubal,Jonathon Leipsic,Philipp Blanke,Feifan Zhang,Rupa Parvataneni,Maria Alu,Howard C. Herrmann,Raj Makkar,Michael J. Mack,Richard W. Smalling,Martin B. Leon,Vinod H. Thourani,Susheel Kodali +21 more
TL;DR: At least moderate PVR was rare but associated with increased risk of death and heart failure rehospitalization at 1 year, and even the upper range of the mild class in the 3-class grading scheme had no significant effect on short-term mortality or re Hospitalization.